Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 1
2(33.3%)
Phase 2
2(33.3%)
Phase 3
2(33.3%)
6Total
Phase 1(2)
Phase 2(2)
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07219654Phase 2Not Yet Recruiting

Efficacy and Safety Study of TPX-115 on Partial-thickness Rotator Cuff Tear

Role: lead

NCT06533540Phase 1Active Not Recruiting

Safety Study of TPX-121 on Nasolabial Folds

Role: lead

NCT06414005Phase 2Recruiting

A Phase 2b/3 Study of TPX-115 on Partial-thickness Rotator Cuff Tear

Role: lead

NCT06197789Phase 3Completed

Safety and Efficacy Study of TPX-105 for Correction of Nasojugal Groove

Role: lead

NCT03668028Phase 3Completed

A Phase I/III Clinical Study of TPX-114 for the Treatment of Full-Thickness Rotator Cuff Tear

Role: lead

NCT04470167Phase 1Completed

Phase 1/2 Clinical Study of TPX-115 in Patients With Partial-Thickness Rotator Cuff Tear

Role: lead

All 6 trials loaded